Literature DB >> 2315486

Bone scans with one or two new abnormalities in cancer patients with no known metastases: frequency and serial scintigraphic behavior of benign and malignant lesions.

A F Jacobson1, E B Cronin, P C Stomper, W D Kaplan.   

Abstract

Scintigraphic, radiologic, and clinical follow-up findings were reviewed in cases in which bone scans (n = 301) showed one or two new abnormalities in patients with malignancy but no known metastases. Metastatic disease was confirmed for 25 of 231 scans (11%) with one new abnormality and for 17 of 70 scans (24%) with two new abnormalities. The prevalence of metastases was 0.06 to 0.13 for lesions in all regions of the skeleton, except the sternum (three of six) and the pelvis (10 of 32). On follow-up scans, in the absence of an interval change in therapy, 19 of 21 metastases became more intense, whereas most benign abnormalities either remained unchanged (47%) or resolved (41%). Benign lesions in the ribs, extremities, and pelvis generally resolved within 12-24 months, while most benign skull and spine abnormalities were still apparent after 35-58 months of follow-up.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315486     DOI: 10.1148/radiology.175.1.2315486

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

Review 1.  Staging for M disease.

Authors:  T L Winton
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

2.  Overview of samarium sm 153 lexidronam in the treatment of painful metastatic bone disease.

Authors:  Oliver Sartor
Journal:  Rev Urol       Date:  2004

3.  Risk of metastasis among rib abnormalities on bone scans in breast cancer patients.

Authors:  Qin Li; Zhiqiang Chen; Yansheng Zhao; Xiuqing Li; Hong Pan; Tiansong Xia; Lin Chen; Zhaoqiang Xu; Wenbin Zhou; Xiaoan Liu
Journal:  Sci Rep       Date:  2015-05-05       Impact factor: 4.379

4.  The need for bone biopsies in the diagnosis of new bone lesions in patients with a known primary malignancy: A comparative review of 117 biopsy cases.

Authors:  Liang Zhang; Yichao Wang; Yutong Gu; Yingyong Hou; Zixian Chen
Journal:  J Bone Oncol       Date:  2018-12-18       Impact factor: 4.072

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.